NCL News Archive

Wednesday, March 15, 2017

Video Overview of NCL Services

Not sure what the NCL does or how we might work together? Watch the NCL’s overview video to learn more about the services we offer.

Learn more about NCL’s free characterization service for cancer nanomedicines and the types of fee-based services we provide. Contact us with any questions. A staff member will be happy to answer... View Post


Friday, March 3, 2017

Equivalence of Complex Drug Products: Scientific and Regulatory Challenges

Missed the NYAS meeting on “Equivalence of Complex Drug Products: Scientific and Regulatory Challenges”? The academy has just published an e-briefing from the meeting. Here you will be able to find notes from the meeting, as well as videos of select presentations. You can also find links to related publications and websites.

The meeting was co-organized by the Non Biological... View Post


Thursday, February 2, 2017

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.

The first issue of ACS Nano for 2017 features an article on the “Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.” The article, co-authored by NCL’s Senior Immunologist, Marina Dobrovolskaia, along with several other well-known names in the field, summarizes the topics of discussion from a recent meeting on the subject. The two-day workshop was held... View Post


Tuesday, December 6, 2016

Nature Reviews Materials

NCL’s Director, Scott McNeil, recently published a Correspondence article in Nature Reviews Materials. “Evaluation of nanomedicines: Stick to the basics”, was written in response to another recent Nature Reviews Materials article, Wilhelm, et al, Nature Reviews Materials, 2016, 1, 16014. The Wilhelm, et al. article provides a retrospective analysis of nanoparticle drug... View Post


Tuesday, December 6, 2016

Join our LinkedIn group on Nanomedicine Preclinical Development

NCL has created a focus group on LinkedIn, designed to connect researchers within the nanotech field. The aim of the group will be to discuss the latest news, trends, and issues of Nanomedicine Preclinical Development.

Join here: https://www.linkedin.com/groups/8555666


Tuesday, December 6, 2016

Nature Reviews publication

The NCL has recently published a review article entitled “Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer” in Nature Reviews Clinical Oncology. The review highlights current nanomedicine strategies being used to target one of the most devastating cancers.

Find the Advance Online publication here: http://www.nature.com/nrclinonc/journal/vaop/... View Post


Monday, November 28, 2016

Nanomedicine Pharmacokinetics Publication

NCL’s Sr. Principal Scientist in Pharmacology & Toxicology, Dr. Stephan Stern, has spearheaded several important publications on the complexity of nanomedicine pharmacokinetics and the importance of measuring all drug fractions—nanomedicine encapuslated, protein-bound, and free unbound drug—when evaluating nanomedicine PK. The most recent of these publications is entitled “When Is It... View Post


Monday, November 28, 2016

NCL Lessons Learned Workshop Videocast

The NCL recently hosted its 8th edition of the popular Lessons Learned Workshop (LLW) seminar series. This year’s meeting was condensed into an intensive half-day series of talks covering topics such as strategies for evaluating batch-to-batch consistency, surface characterization, nanomaterial ADME/Tox and PK, sterility and endotoxin contamination, immunotoxicity, and linking physicochemical... View Post


Monday, September 26, 2016

AAPS Journal Themed Issue

The AAPS Journal is compiling a themed issue entitled “Nanotechnology in Complex Drug Products: Learning from the Past, Preparing for the Future.” The issues aims to discuss characterization, manufacturing, and regulatory challenges in nanotechnology drug products. NCL’s contribution to this collection, “Early Development Challenges for Drug Products Containing Nanomaterials” has just been... View Post


Pages